Sunshine Biopharma Inc (NASDAQ:SBFM) traded at $0.86 at close of the session on Monday, April 29, made a downward move of -9.64% on its previous day’s price.
Looking at the stock we see that its previous close was $0.95. In terms of its 52-week price range, SBFM has a high of $140.00 and a low of $0.75. The company’s stock has lost about -85.81% over that past 30 days.
Sunshine Biopharma Inc has a market cap of $0.85 million. Estimates by analysts give the company expected earnings per share (EPS) of -$8, with the EPS growth for the year raised at $3 for 2024 and $17 for next year. These figures represent 115.80% and 466.70% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $7 million, with a low of $7 million and a high of $7 million. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $44.4 million, or 84.30% up from figures reported last year.
On the other hand, looking at the outlook for the SBFM stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -85.93% off its SMA20 and -85.50% from its 50-day simple moving average. The RSI (14) is pointing at 29.86 while the volatility over the past week is 26.28% and jumps to 29.04% over the past one month. The beta value is -0.86, while the average true range (ATR) is currently pointing at 1.35.
Coming back to Sunshine Biopharma Inc (NASDAQ:SBFM), we note that the average 3-month trading volume was 1.66 million. Current shares outstanding are 0.99 million.
The insiders hold 4.14% of the company’s shares while institutions hold 11.83%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -96.84% down in year-to-date price movement.
